Advanced Solid Malignancies Recruiting Phase 1 Trials for Abiraterone (DB05812)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02740985A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid MalignanciesTreatment